Arif Nathoo, MD

Arif Nathoo, MD, is the CEO and cofounder of Komodo Health.

Articles by Arif Nathoo, MD

Image credit: Medical technology and futuristic concept. Doctor hologram modern virtual screen interface | SOMKID - stock.adobe.com

Physician-Led Tech Firms Use AI to Counter Drug Denials and Augment Appeals

ByGiuliana Grossi,Pearl Steinzor,Arif Nathoo, MD,Christopher Gold, DO,Michael Gao, MD

April 16th 2025

As drug denials increase, experts discuss the importance of optimizing data to keep up with these changes and implementing artificial intelligence (AI) to reduce the burden on providers and ensure patient access to care and treatment.

Arif Nathoo, MD

Articles by Arif Nathoo, MD

Physician-Led Tech Firms Use AI to Counter Drug Denials and Augment Appeals

Latest Updated Articles

Trending on AJMC

Three Years on Baricitinib Preserved Hair Regrowth in Severe Alopecia Areata

First Clinical Evidence of Gene Editing, Epigenetic Silencing of HBV cccDNA

Oz White House Briefing Touts Drug Savings and Fraud Cleanup, but Data Tell a Nuanced Story

5 Notable Oncology FDA Approvals Granted in May

Delgocitinib Coverage Could Save Health Plans $88M Over 3 Years

Arif Nathoo, MD

Articles by Arif Nathoo, MD

​​Physician-Led Tech Firms Use AI to Counter Drug Denials and Augment Appeals

Latest Updated Articles

Trending on AJMC

Three Years on Baricitinib Preserved Hair Regrowth in Severe Alopecia Areata

First Clinical Evidence of Gene Editing, Epigenetic Silencing of HBV cccDNA

Oz White House Briefing Touts Drug Savings and Fraud Cleanup, but Data Tell a Nuanced Story

5 Notable Oncology FDA Approvals Granted in May

Delgocitinib Coverage Could Save Health Plans $88M Over 3 Years

Physician-Led Tech Firms Use AI to Counter Drug Denials and Augment Appeals